NCT02516241 2026-04-20Study of MEDI4736 (Durvalumab) With or Without Tremelimumab Versus Standard of Care Chemotherapy in Urothelial CancerAstraZenecaPhase 3 Active not recruiting1,126 enrolled 52 charts
NCT02891161 2024-11-27DUARTBig Ten Cancer Research ConsortiumPhase 1/2 Terminated26 enrolled 20 charts